{"id":256392,"date":"2015-01-08T12:50:48","date_gmt":"2015-01-08T17:50:48","guid":{"rendered":"http:\/\/www.eugenesis.com\/movers-shakers-wd-40-shares-slip-as-results-fall-below-street-view\/"},"modified":"2015-01-08T12:50:48","modified_gmt":"2015-01-08T17:50:48","slug":"movers-shakers-wd-40-shares-slip-as-results-fall-below-street-view","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/movers-shakers-wd-40-shares-slip-as-results-fall-below-street-view.php","title":{"rendered":"Movers &#038; Shakers: WD-40 shares slip as results fall below Street view"},"content":{"rendered":"<p><p>    SAN FRANCISCO (MarketWatch)  Shares of WD-40 Co. slipped in    the extended session Wednesday on an earnings miss.  <\/p>\n<p>    WD-40 WDFC,    -3.33%    shares fell 5.2% to $81 on light volume after the    companys fiscal first-quarter results fell short of    Wall Street expectations.  <\/p>\n<p>    Shares of NephroGenex Inc. NRX,    +5.21%    rose 19% to $10.99 on moderate volume after the    clinical-stage drug company said late-stage studies on its    diabetic nephropathy treatment Pyridorin would be able to    support a marketing application in Europe. The company also    disclosed that RHO Capital had taken an 11.9% stake in the    company.  <\/p>\n<p>    Bind Therapeutics Inc. BIND,    +58.83%    shares jumped 26% to $6.50 on moderate volume. The    nanomedicine platform company said it expects one of its    collaboration partners will file a drug application with the    FDA by mid-2015 using their Accurin drug delivery particles.  <\/p>\n<p>    Mistras Group Inc. MG, +12.53% shares rose    13% to $20.63 on light volume after the company reported fiscal    second-quarter earnings of 33 cents a share on revenue of    $206.9 million. Analysts had estimated 26 cents a share on    revenue of $186.2 million.  <\/p>\n<p>    Alexion Pharmaceuticals    Inc. ALXN,    -2.21%    shares fell 4.8% to $179 in late trading after the    company said a phase 2 clinical trial of eculizumab -- a drug    to help prevent rejection of kidney transplants -- failed to meet its primary composite    endpoint.  <\/p>\n<p>    Insulet Corp. PODD,    -8.16%    shares fell 7.9% to $41 on moderate volume after the    insulin pump company said it expects fourth-quarter revenue of    $71 million to $73 million, down from a previous estimate of    $76 million to $81 million, because of a delay in product    shipments. Analysts had expected $79.6 million.  <\/p>\n<p>    Zumiez Inc. ZUMZ,    -0.65%    shares rose 2.7% to $41.35 on light volume after the    specialty retailer raised its guidance for the fourth    quarter.  <\/p>\n<p>    These were the stocks making notable moves during the regular    session Wednesday:  <\/p>\n<p>    Keurig Green Mountain Inc. GMCR,    +2.30% signed a    deal with Dr Pepper Snapple Group Inc.    DPS, +1.67%  to sell    capsules that make its sodas in Keurigs planned cold-drink machine.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the rest here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.marketwatch.com\/news\/story.asp?guid=%7B08F45938-95E6-11E4-8C16-B1B4F49F1069%7D&siteid=rss&rss=1\/RK=0\/RS=_dOAx0eoAMcA.ayk2vORicUMtIA-\" title=\"Movers &amp; Shakers: WD-40 shares slip as results fall below Street view\">Movers &amp; Shakers: WD-40 shares slip as results fall below Street view<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SAN FRANCISCO (MarketWatch) Shares of WD-40 Co. slipped in the extended session Wednesday on an earnings miss <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/movers-shakers-wd-40-shares-slip-as-results-fall-below-street-view.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577779],"tags":[],"class_list":["post-256392","post","type-post","status-publish","format-standard","hentry","category-nanomedicine-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256392"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=256392"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256392\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=256392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=256392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=256392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}